Analysis of PD-L1 (epitope 1) (Human) by MSD Hypersensitive Multi-Factor Electrochemiluminescence Analyzer (CAT#: STEM-MB-0487-LGZ)

Introduction

PD-L1 expression is one of the most widely used immunotherapy biomarkers in clinical practice. A series of clinical research results have confirmed that the PD-L1 expression level of tumor cells and/or tumor-associated immune cells is closely related to the efficacy of immunotherapy and the prognosis of patients.